Intech Biopharm Corporation (6461.TWO)
TWD 18.3
(-9.63%)
TWD 18.3
(-9.63%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | -163.99 Million TWD | -8.4% |
| 2022 | 170.81 Million TWD | -2.17% |
| 2021 | 174.61 Million TWD | 71.74% |
| 2020 | 101.67 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 47.34 Million TWD | -208.22% |
| 2024 Q1 | 38.19 Million TWD | -25.23% |
| 2023 Q1 | 37.04 Million TWD | -28.15% |
| 2023 Q4 | 51.08 Million TWD | 37.29% |
| 2023 FY | 156.47 Million TWD | -8.4% |
| 2023 Q2 | 31.13 Million TWD | -15.96% |
| 2023 Q3 | 37.2 Million TWD | 19.51% |
| 2022 Q4 | 51.56 Million TWD | 0.0% |
| 2022 FY | 170.81 Million TWD | -2.17% |
| 2021 FY | 174.61 Million TWD | 71.74% |
| 2020 FY | 101.67 Million TWD | 0.0% |
| 2019 FY | - TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 228.452% |
| Level Biotechnology Inc. | 151.99 Million TWD | 207.896% |
| Sagittarius Life Science Corp | 135.85 Million TWD | 220.715% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | 316.184% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 172.811% |
| GlycoNex Incorporation | 995 Thousand TWD | 16581.91% |
| VBI | 32.55 Million TWD | 603.748% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | 163.844% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 184.453% |
| Visgeneer Inc. | 67.48 Million TWD | 343.02% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 56.29% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 132.15% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 356.631% |
| Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 111.357% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | 658.718% |
| Enimmune corporation | 220.1 Million TWD | 174.509% |
| TaiRx, Inc. | 217.13 Million TWD | 175.527% |
| CHO Pharma, Inc. | 268.99 Million TWD | 160.965% |
| EirGenix Inc. | 236.74 Million TWD | 169.272% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 257.157% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | 145.857% |
| Lin BioScience, Inc. | 1.09 Billion TWD | 114.952% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 161.615% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | 431.497% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | 15242.659% |
| Lukas Biomedical Inc. | 177.45 Million TWD | 192.418% |
| RBC Bioscience Corporation | 58.35 Million TWD | 381.025% |
| BiOptic Inc. | 108.69 Million TWD | 250.88% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | 182316.667% |
| Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 336.474% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | 6371.319% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 125.468% |
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | 49946.505% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | 456.333% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 236.765% |
| Neith Corporation | 66.87 Million TWD | 345.234% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 275.704% |
| NaviFUS Corp. | 11.82 Million TWD | 1486.615% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 185.983% |
| Sinew Pharma Inc. | 186.25 Million TWD | 188.05% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 321.546% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 174.409% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 495.35% |
| AP Biosciences Inc | 32.25 Million TWD | 608.464% |
| Medigen Biotechnology Corp. | 1.85 Billion TWD | 108.863% |
| 3D Global Biotech Inc. | 5.27 Million TWD | 3209.499% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | 151.681% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 114.523% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | 495.34% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | 196.72% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 211.545% |
| TCI GENE Inc. | 174.61 Million TWD | 193.917% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | 911183.333% |
| Senhwa Biosciences, Inc. | 300.93 Million TWD | 154.495% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 156.364% |
| NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 295.36% |
| PharmaEngine, Inc. | 441.78 Million TWD | 137.121% |
| Savior Lifetec Corporation | 223.36 Million TWD | 173.419% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 163.373% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 108.133% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 218.092% |
| Acepodia, Inc. | 452.56 Million TWD | 136.237% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 130.317% |